Beximco Pharma Clarifies Position Amid Legal Challenge

Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update.

Beximco Pharmaceuticals Limited has clarified its position regarding a Writ Petition filed by a lawyer in the Supreme Court of Bangladesh, stressing that the company is not involved in the financial misdeeds of the broader Beximco Group, as it is a publicly listed entity with diverse shareholders. The Supreme Court has issued an interim order to appoint a receiver for Beximco Group companies, but Beximco Pharmaceuticals argues this does not affect them and is contesting its inclusion in the petition. The company plans to take necessary actions to establish its legal stance and will inform stakeholders of any further developments.

For further insights into GB:BXP stock, check out TipRanks’ Stock Analysis page.